0001415889-24-004704.txt : 20240221 0001415889-24-004704.hdr.sgml : 20240221 20240221211050 ACCESSION NUMBER: 0001415889-24-004704 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horn Kinney CENTRAL INDEX KEY: 0001831215 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 24662017 MAIL ADDRESS: STREET 1: C/O OLEMA PHARMACEUTICALS, INC. STREET 2: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 4 1 form4-02222024_020242.xml X0508 4 2024-02-20 0001472012 Immunome Inc. IMNM 0001831215 Horn Kinney C/O IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 EXTON PA 19341 false true false false CHIEF BUSINESS OFFICER 0 Stock option (right to buy) 23 2024-02-20 4 A 0 300000 0 A 2034-02-19 Common Stock 300000 300000 D 25% of the shares subject to the options vest on February 12, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter. /s/ Sandra Stoneman, Attorney-in-Fact 2024-02-21